Hrt Financial LP Morphic Holding, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$19.95 - $31.0 $260,626 - $404,984	13,064 New	13,064 $377,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $970,806 - $1.46 Million	43,671 New	43,671 $1.24 Million
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $343,258 - $494,313	-7,606 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $226,430 - $645,369	7,606 New	7,606 $481,000

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.